Navigation Links
Bayer to Present Data on Investigational Oncology Compounds at 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Date:5/17/2011

ary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions.  As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women's Healthcare.  The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

BAYER® and the Bayer Cross® are trademarks of Bayer.

Contact:
David Freundel, 973-305-5310
E-Mail: david.freundel@bayer.com

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire-USNewswire/ ... that allows Kessler Foundation and New Jersey Health ... research, education and patient care programs has been ... chief executive officer of Kessler Foundation and ... Health Foundation. "The experience of New ...
(Date:9/30/2014)... 2014  Georgia-Pacific Professional is a leading provider ... a wide range of away from home applications. ... in healthcare, including hospitals, long-term care facilities, surgical ... its healthcare products and solutions to the dental ... of infection control in the dental office," said ...
(Date:9/30/2014)... -- In a recent study it was ... the Eldor spinal needle 25G, 103 mm appeared significantly ... spinal needles of the same gauge and length of ... an excellent type of regional anesthesia for many operations ... It is estimated that 100 million patients worldwide ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
... 26, 2011 Clermont Pharmaceuticals, Inc., a ... positive results from a phase III trial ... latanoprost was compared to Xalatan® (latanoprost ophthalmic ... glaucoma.  Non-preserved latanoprost achieved the primary efficacy ...
Cached Medicine Technology:Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma 2
(Date:9/30/2014)... September 30, 2014 Coast Dental ... opening of its newest practice, located at 1010 Shaw ... x-rays, general dentistry services , and specialty dental ... addition to providing affordable and convenient dental care, our ... dental appointments . Call Coast Dental at 559-777-6113 to ...
(Date:9/30/2014)... September 30, 2014 In its latest blog ... and believes that having family close by during a stay ... not the process is successful, is focusing on 5 reasons ... lasting recovery. , “Achieving sobriety is not a one-time event, ... Drug Rehabilitation’s CEO Per Wickstrom . “It’s an ongoing ...
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... Rochelle, NY, September 30, 2014Levothyroxine (L-T4), long the ... in most patients, but some individuals do not ... about thyroid physiology may help to explain these ... Thyroid Association on thyroid hormone replacement reviewed the ... treatments to determine whether a change to the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 OZ Naturals ... selling beauty brand on Amazon.com. , “The majority of ... respective beauty categories on Amazon.com,” said Craig Romero, CEO of ... UK on Amazon.co.uk and Canada on Amazon.ca , Romero went ... just launched earlier last month, are already taking over top ...
Breaking Medicine News(10 mins):Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 2Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 3Health News:How to predict who will suffer the most from stress 2Health News:New hypothyroidism treatment guidelines from American Thyroid Association 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3
... More than nine million people, or 34 percent of ... drug benefit through Medicare Advantage plans with prescription drug ... Using just released data from the Center for ... database, Avalere researchers analyzed 2009 Medicare Part D open ...
... ST. LOUIS, Feb. 24 The deepening economic ... some would say failing -- health care,system at ... number of,uninsured and underinsured is rising. Also, faced ... those with insurance are not compliant in,taking critical ...
... and states reconsider funding for abstinence-only programs, the largest ... classes reveals that abstinence programs are plagued with factual ... and actively discourage the use of condoms to protect ... Texas Freedom Network Education Fund - Just Say ...
... women, but different genes might raise risk in black women ... a genetic marker that may indicate if a woman has ... says. , Shorter, white women who test positive for the ... to develop the muscular tumors in their uterus, according to ...
... study published in the February 2009 issue of the ... a highly reliable depression screening tool known as the ... and Europe can be effectively administered in resource poor ... needs have been underserved. The work also confirms that ...
... U.S. editors and producers traveled to Uganda last year ... fascinating countries. A highlight of the International Reporting Project ... and HIV/AIDS with Ugandan President Yoweri Museveni. At the ... three of the Gatekeepers will discuss the U.S. media,s ...
Cached Medicine News:Health News:1 in 3 Medicare Part D Enrollees Select Medicare Advantage Drug Plans for 2009 2Health News:Health and Wellness Programs in a Tight Economy: Why They Are Critical and How to Make Them Effective 2Health News:New Texas Study Reveals Serious Flaws in Abstinence Programs 2Health News:Inexpensive depression screening tool works in resource poor countries 2Health News:U.S. Media Report From Uganda: Wilson Center Panel Discusses Health, Environment, and Security in Africa 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
Medicine Products: